Research and Markets: Chinese Drug Recall Regulations Industry Analysis 2015-2020
- Submitted by: HexaReports99
- Views: 68
- Category: Other
- Date Submitted: 11/16/2015 01:57 AM
- Pages: 3
- Report this Essay
Hexa Reports
Market Research Reports and Insightful Company Profiles
Latest guidebook for Chinese Drug Recall Regulations (2014
Edition)
China is one of the fastest growing global economies with a fifth population in the world, and is one of
the largest healthcare markets around the world. Along with sustained economic and population
growth, Chinese healthcare market has maintained annually average growth rate above 16 % since
1990s. By 2013, total value of drugs on Chinese healthcare market has reached RMB 1114 billion. On the
Chinese healthcare market, imported drugs made by overseas and multinational pharmaceutical
manufacturers account for about one fourth. It is estimated that total value of drugs on Chinese
healthcare market will be likely to be more than RMB 1450 billion by 2015, and will surpass Japan to
become the second largest drug market following the United States. The Chinese healthcare market will
attract more and more overseas pharmaceutical manufacturers and producers to penetrate such
market.
Browse Detail Report With TOC @ http://www.hexareports.com/report/latest-guidebook-forchinese-drug-recall-regulations/details
Latest guidebook for Chinese Drug Recall Regulations (2014 Edition) is an essential resource for overseas
and multinational pharmaceutical manufacturers and producers to handle a drug recall smoothly in
China, which provides a detailed guidance of comprehensive and thorough knowledge of the Chinese
drug recall regulations.
Hexa Reports
Market Research Reports and Insightful Company Profiles
Table Of Content
Chapter 1 Introduction.2
Chapter 2 An Overview of Chinese Regulatory Authorities for Drug Recall.4
Request A Sample copy of This Report @ http://www.hexareports.com/sample/50880
Chapter 3 General Regulations for Drug Recall.6
3.1. Definitions.6
3.2. The special regulations for overseas manufacturers of imported drugs.6
3.3. Who, Where and How to Submit the Report relating to Drug Recall?.6
3.4....
Market Research Reports and Insightful Company Profiles
Latest guidebook for Chinese Drug Recall Regulations (2014
Edition)
China is one of the fastest growing global economies with a fifth population in the world, and is one of
the largest healthcare markets around the world. Along with sustained economic and population
growth, Chinese healthcare market has maintained annually average growth rate above 16 % since
1990s. By 2013, total value of drugs on Chinese healthcare market has reached RMB 1114 billion. On the
Chinese healthcare market, imported drugs made by overseas and multinational pharmaceutical
manufacturers account for about one fourth. It is estimated that total value of drugs on Chinese
healthcare market will be likely to be more than RMB 1450 billion by 2015, and will surpass Japan to
become the second largest drug market following the United States. The Chinese healthcare market will
attract more and more overseas pharmaceutical manufacturers and producers to penetrate such
market.
Browse Detail Report With TOC @ http://www.hexareports.com/report/latest-guidebook-forchinese-drug-recall-regulations/details
Latest guidebook for Chinese Drug Recall Regulations (2014 Edition) is an essential resource for overseas
and multinational pharmaceutical manufacturers and producers to handle a drug recall smoothly in
China, which provides a detailed guidance of comprehensive and thorough knowledge of the Chinese
drug recall regulations.
Hexa Reports
Market Research Reports and Insightful Company Profiles
Table Of Content
Chapter 1 Introduction.2
Chapter 2 An Overview of Chinese Regulatory Authorities for Drug Recall.4
Request A Sample copy of This Report @ http://www.hexareports.com/sample/50880
Chapter 3 General Regulations for Drug Recall.6
3.1. Definitions.6
3.2. The special regulations for overseas manufacturers of imported drugs.6
3.3. Who, Where and How to Submit the Report relating to Drug Recall?.6
3.4....